Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Analysis

September’s top stories: US researchers developed Epilepsy drugs, GE’s €150 million biopharmaceutical campus investment

Researchers at Columbia University Medical Centre (CUMC) identified how anti-epileptic drug Perampanel blocks AMPA receptors in the brain, and GE planned to invest €150 million in a new biopharmaceutical manufacturing campus at Ireland. Pharmaceutical-technology.com wraps up the key headlines from September.

Go Top